한국인 조현병 환자에서 Chromogranin B 유전자와 안구운동 이상의 연합에 대한 연구 = Association Analysis between Chromogranin B Genetic Variations and Smooth Pursuit Eye Movement Abnormality in Korean Patients with Schizophrenia

다국어 초록 (Multilingual Abstract)

Objectives According to previous studies, the Chromogranin B (CHGB) gene could be an important candidate gene for schizophrenia which is located on chromosome 20p12.3. Some studies have linked the polymorphism in CHGB gene with the risk of schizophrenia. Meanwhile, smooth pursuit eye movement (SPEM) abnormality has been regarded as one of the most consistent endophenotype of schizophrenia. In this study, we investigated the association between the polymorphisms in CHGB gene and SPEM abnormality in Korean patients with schizophrenia. Methods We measured SPEM function in 24 Korean patients with schizophrenia (16 male, 8 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated genotypes of polymorphisms in CHGB gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and the number of polymorphism. Results The natural logarithm value of signal/noise ratio (Ln S/N ratio) of good SPEM function group was $4.19{\pm}0.19$ and that of poor SPEM function group was $3.17{\pm}0.65$. In total, 15 single nucleotide polymorphisms of CHGB were identified and the genotypes were divided into C/C, C/R, and R/R. Statistical analysis revealed that two genetic variants (rs16991480, rs76791154) were associated with SPEM abnormality in schizophrenia (p = 0.004). Conclusions Despite the limitations including a small number of samples and lack of functional study, our results suggest that genetic variants of CHGB may be associated with SPEM abnormality and provide useful preliminary information for further study.nwhile, smooth pursuit eye movement (SPEM) abnormality has been regarded as one of the most consistent endophenotype of schizophrenia. In this study, we investigated the association between the polymorphisms in CHGB gene and SPEM abnormality in Korean patients with schizophrenia. MethodsZZWe measured SPEM function in 24 Korean patients with schizophrenia (16 male, 8 female) and they were divided according to SPEM function into two groups, good and poor SPEM function groups. We also investigated genotypes of polymorphisms in CHGB gene in each group. A logistic regression analysis was performed to find the association between SPEM abnormality and the number of polymorphism. ResultsZZThe natural logarithm value of signal/noise ratio (Ln S/N ratio) of good SPEM function group was $4.19{\pm}0.19$ and that of poor SPEM function group was $3.17{\pm}0.65$. In total, 15 single nucleotide polymorphisms of CHGB were identified and the genotypes were divided into C/C, C/R, and R/R. Statistical analysis revealed that two genetic variants (rs16991480, rs76791154) were associated with SPEM abnormality in schizophrenia (p = 0.004). ConclusionsZZDespite the limitations including a small number of samples and lack of functional study, our results suggest that genetic variants of CHGB may be associated with SPEM abnormality and provide useful preliminary information for further study.

참고문헌 (Reference)

1 이창희, "한국인에서 정신분열병환자의 안구추적운동 이상과 Dystrobrevin Binding Protein 1 (DTNBP1) 유전자의 SNP　A(T>A)와 P1763(A>C) 다형성의 연합에 대한 연구" 대한생물정신의학회 13 (13): 275-284, 2006

2 Davidsson P, "The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains" 40 : 23-29, 1999

3 Selemon LD, "The reduced neuropil hypothesis : a circuit based model of schizophrenia" 45 : 17-25, 1999

4 Huttner WB, "The granin(chromogranin/secretogranin)family" 16 : 27-30, 1991

5 Krauzlis RJ, "The control of voluntary eye movements : new perspectives" 11 : 124-137, 2005

6 Taupenot L, "The chromogranin-secretogranin family" 348 : 1134-1149, 2003

7 Owen MJ, "Schizophrenia: genes at last?" 21 : 518-525, 2005

8 Picchioni MM, "Schizophrenia" 335 : 91-95, 2007

9 van Os J, "Schizophrenia" 374 : 635-645, 2009

10 Gamo NJ, "Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction" 3 : e328-, 2013

11 Huttner WB, "Regulated secretion. Helper proteins for neuroendocrine secretion" 5 : 242-245, 1995

12 Nowakowski C, "Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia" 58 : 43-53, 2002

13 Landén M, "Reduction of chromogranin A and B but not C in the cerebrospinal fluid in subjects with schizophrenia" 9 : 311-315, 1999

14 Doherty JL, "Recent genomic advances in schizophrenia" 81 : 103-109, 2012

15 Arnold SE, "Recent advances in defining the neuropathology of schizophrenia" 92 : 217-231, 1996

16 Kroesen S, "Rat brain: distribution of immunoreactivity of PE-11, a peptide derived from chromogranin B" 8 : 2679-2689, 1996

17 Lencer R, "Pursuit eye movements as an intermediate phenotype across psychotic disorders : evidence from the B-SNIP study" 169 : 326-333, 2015

18 Zhang B, "Polymorphisms of chromogranin B gene associated with schizophrenia in Chinese Han population" 323 : 229-233, 2002

19 Lencer R, "Neurophysiology and neuroanatomy of smooth pursuit in humans" 68 : 219-228, 2008

20 Pasaje CF, "Neuregulin 3 does not confer risk for schizophrenia and smooth pursuit eye movement abnormality in a Korean population" 10 : 828-833, 2011

21 Harrison PJ, "Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology" 60 : 132-140, 2006

22 Chanat E, "Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network" 115 : 1505-1519, 1991

23 Kim JH, "Lack of associations of neuregulin 1 variations with schizophrenia and smooth pursuit eye movement abnormality in a Korean population" 46 : 476-482, 2012

24 Gorr SU, "Interaction of calcium with porcine adrenal chromogranin A (secretory protein-I) and chromogranin B (secretogranin I)" 257 : E247-E254, 1989

25 Kim LH, "Genome-wide association study with the risk of schizophrenia in a Korean population" 171B : 257-265, 2016

26 Lencer R, "Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the BSNIP study" 7 : e1249-, 2017

27 신중곤, "Gender-Specific Associations between CHGB Genetic Variants and Schizophrenia in a Korean Population" 연세대학교의과대학 58 (58): 619-625, 2017

28 Wu S, "Further evidence that the chromogranin B gene confers predisposition to schizophrenia : a family-based association study in Chinese" 114 : 641-644, 2007

29 Bauer R, "Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs" 23 : 46-55, 2000

30 Marksteiner J, "Distribution of chromogranin B-like immunoreactivity in the human hippocampus and its changes in Alzheimer’s disease" 100 : 205-212, 2000

31 Chen XW, "DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release" 181 : 791-801, 2008

32 Díaz-Vera J, "Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles" 30 : 950-957, 2010

33 Weinberger DR, "Cell biology of the hippocampal formation in schizophrenia" 45 : 395-402, 1999

34 Zhang K, "Autonomic function in hypertension; role of genetic variation at the catecholamine storage vesicle protein chromogranin B" 2 : 46-56, 2009

35 Iijima Y, "Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese population" 56 : 10-17, 2004

36 Lee YJ, "Association analysis between the G72/G30 single nucleotide polymorphisms (rs947267 and rs77829) and smooth pursuit eye movement (SPEM)abnormalities of patients with schizophrenia in Korean population" 13 : 42-49, 2010

37 Eastwood SL, "Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia" 66 : 309-319, 1995

38 Karayiorgou M, "A turning point in schizophrenia genetics" 19 : 967-979, 1997